Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-06 · accession 0001209191-21-045995 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-08 | 2021-07-06 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $9.24 | +15.0K | 909.3K | +2% | +$138.7K |
| DM | 2021-07-08 | 2021-07-06 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $193.08 | -15.0K | 909.4K | -2% | -$2.90M |
| DM | 2021-07-08 | 2021-07-06 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -15.0K | 77.7K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-06 | M | A | 9,792 | $11.48 | 919,068 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-07-06 | S | D | 900 | $190.12 | 918,168 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $189.54 to $190.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-07-06 | S | D | 1,700 | $191.07 | 916,468 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $190.65 to $191.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-07-06 | S | D | 4,017 | $192.20 | 912,451 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $191.66 to $192.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-07-06 | S | D | 2,756 | $194.13 | 906,668 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $193.67 to $194.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-07-06 | S | D | 2,000 | $195.12 | 904,668 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $194.68 to $195.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-07-06 | S | D | 500 | $196.33 | 904,168 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $195.92 to $196.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 8 | Common | Class A Common Stock | 2021-07-06 | S | D | 100 | $196.97 | 904,068 | D | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $196.94 to $196.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 9 | Common | Class A Common Stock | 2021-07-06 | M | A | 5,208 | $5.04 | 909,276 | D | — | — | |
| 10 | Common | Class A Common Stock | 2021-07-06 | S | D | 3,027 | $193.27 | 909,424 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $192.67 to $193.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 11 | Derivative | Stock Option (right to buy) | 2021-07-06 | M | D | 5,208 | $0.00 | 79,365 | D | $5.04 · — to 2028-11-02 | 5,208 Class A Common Stock | (F11) This option, originally for 250,000 shares, of which 170,635 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 12 | Derivative | Stock Option (right to buy) | 2021-07-06 | M | D | 9,792 | $0.00 | 77,713 | D | $11.48 · — to 2029-05-10 | 9,792 Class A Common Stock | (F12) This option, originally for 145,786 shares, of which 68,073 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |